IRIS - Res&Arch Institutional Research Information System - Research & Archive

PORCELLATI, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.014
EU - Europa 1.740
AS - Asia 300
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
SA - Sud America 2
AF - Africa 1
Totale 4.062
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.007
IE - Irlanda 381
SE - Svezia 335
UA - Ucraina 311
IT - Italia 294
HK - Hong Kong 137
FI - Finlandia 103
RU - Federazione Russa 98
DE - Germania 78
VN - Vietnam 76
GB - Regno Unito 48
CN - Cina 45
FR - Francia 29
AT - Austria 18
TR - Turchia 13
CH - Svizzera 12
BE - Belgio 10
PL - Polonia 7
SG - Singapore 7
UZ - Uzbekistan 7
CA - Canada 6
RO - Romania 6
NL - Olanda 5
IN - India 4
JP - Giappone 4
EU - Europa 3
AU - Australia 2
BD - Bangladesh 2
BR - Brasile 2
GR - Grecia 2
KR - Corea 2
LB - Libano 2
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
ID - Indonesia 1
IM - Isola di Man 1
LU - Lussemburgo 1
MX - Messico 1
Totale 4.062
Salva come PNG Salva come JPEG
Città #
Chandler 474
Dublin 381
San Mateo 223
Jacksonville 159
Hong Kong 137
Altamura 112
Medford 109
Princeton 109
Wilmington 92
Lawrence 80
Ann Arbor 79
Dong Ket 76
Perugia 73
Andover 53
Beijing 38
Des Moines 38
Saint Petersburg 27
Woodbridge 23
Boardman 22
Helsinki 21
Norwalk 21
Falls Church 20
Rome 20
Los Angeles 17
Amelia 15
Ashburn 14
Izmir 13
New York 12
Brussels 10
Moscow 10
Vienna 9
San Paolo di Civitate 8
Auburn Hills 7
Redmond 7
Fremont 6
Bucu 5
Chicago 4
Houston 4
Milan 4
Terni 4
Den Haag 3
Guangzhou 3
Lappeenranta 3
Occhiobello 3
Redwood City 3
San Diego 3
Shanghai 3
Surrey 3
Tappahannock 3
Torino 3
Brendola 2
Dhaka 2
Fairfield 2
Frankfurt Am Main 2
Hyderabad 2
Lausanne 2
Leawood 2
Manassas 2
Nürnberg 2
Osoppo 2
Padova 2
Pisa 2
Plaistow 2
Seoul 2
Singapore 2
Swansea 2
Toronto 2
Torre Del Greco 2
Varese 2
Abidjan 1
Amsterdam 1
Belo Horizonte 1
Berlin 1
Brisbane 1
Cepagatti 1
Douglas 1
Edinburgh 1
Falkenstein 1
Florence 1
Groningen 1
Hangzhou 1
Hanover 1
Jakarta 1
Lainate 1
London 1
Mainz 1
Martino 1
Mexico City 1
Mountain View 1
Mumbai 1
Napoli 1
Narni 1
Ottawa 1
Pacatuba 1
Philadelphia 1
Scorzè 1
Spinea 1
Sydney 1
Taranto 1
Trivandrum 1
Totale 2.635
Salva come PNG Salva come JPEG
Nome #
Ipoglicemia da iperinsulinismo organico: un caso di nesidioblastosi dell’adulto. 131
Different brain responses to hypoglycemia induced by equipotent doses of long-acting insulin analog detemir and human regular insulin in humans 110
Adrenaline vs glucagon in the primacy of glucose counterregulation 93
Administration of neutral protamine Hagerdon insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial. 89
Portal vein glucose sensors do not play a major role in modulating physiological responses to insulin-induced hypoglycemia in humans. 69
Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia. 67
Administration of Neutral Protamine Hagedorn insulin at bedtime versus dinner in Type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control: a randomized, controlled trial. 65
EPIDEMIOLOGICAL SURVEY FOR THE DETECTION OF NON–TRAUMATIC LOWER EXTREMITY AMPUTATIONS IN DIABETIC PATIENTS IN THE UMBRIA REGION (ITALY). 64
EFFECT OF PYRIDOXAL 5'-PHOSPHATE AND VALPROICACID ON PHOSPHOLIPID SYNTHESIS INNEUROBLASTOMA NA 63
Fasting insulin has a stronger association with an adverse cardiometabolic risk profile than insulin resistance: the RISC study. 63
Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs 60
Uso dell’analogo ad azione rapida lispro con l’analogo ad azione ritardo glargine nel trattamento intensivo del T1DM 59
Short-term effects of the long-acting insulin analog detemir and human insulin on plasma levels of insulin-like growth factor-I and its binding proteins in humans. 59
Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis. 58
Comparison of pharmacokinetics and-dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes mellitus: a double-blind, randomized, cross-over study. 56
Pivotal role of timely basal insulin replacement after metformin failure in sustaining long-term blood glucose control at a target in Type 2 diabetes. 56
Cognitive function in hypoglycaemia 54
Body weight, not insulin sensitivity or secretion, may predict spontaneous weight changes in nondiabetic and prediabetic subjects: the RISC study. 53
Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population. 50
Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting analogue at mealtime. A three month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime. 49
null 49
Counterregulatory hormone and symptom responses to insulin-induced hypoglycaemia in the postprandial state in humans 49
Shift of glycaemic thresholds for cognitive function in hypoglycaemia unawareness in humans. 49
Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro 49
Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes mellitus. 48
Comparative pharmacodynamic and pharmacokinetic characteristics of subcutaneous insulin glulisine and insulin aspart prior to a standard meal in obese subjects with type 2 diabetes. 48
Circulating palmitoleic acid is an independent determinant of insulin sensitivity, beta cell function and glucose tolerance in non-diabetic individuals: a longitudinal analysis 47
Awareness, identification and prevention of insulin injection-associated lipodystrophies 47
Counterregulatory hormone and symptom responses to insulin-induced hypoglycemia in the postprandial state in humans 46
Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. 46
Responses to hypoglycemia in diabetic autonomic neuropathy. 46
Influence of the ACE gene insertion/deletion polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects. 45
A novel surrogate index for hepatic insulin resistance. 45
Intensive replacement of basal insulin in patients with Type 1 diabetes mellitus given rapid-acting insulin analogue at meal-time: a three-month comparison between administration of NPH four times daily and glargine insulin at dinner or bedtime. 44
Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes. 44
Pharmacokinetics and pharmacodynamic of therapeutic dose of basel insulins NPH, Glargine and Detemir after one week of daily administration at bedtime in Type 2 daibates: a randomized, cross-over study. 44
Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes 44
Effect of cigarette smoking and of a transdermal nicotine delivery system on glucoregulation in type 2 diabetes mellitus 43
Quando “i conti non tornano” (Caso clinico) G It Diabetol Metab 26:172-175 42
Glucagon: the effects of its excess and deficiency on insulin action 42
Insulin therapy and hypoglycemia: the size of the problem 41
Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people. 41
Alternate splicing in human Na+-MI cotransporter gene yelds differentially regulated trasport isoforms 40
Influence of Apolipoproteins on the Association Between Lipids and Insulin Sensitivity: A cross-sectional analysis of the RISC Study 40
Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women. 39
Mechanisms of arterial hypotension after therapeutic dose of subcutaneous insulin in diabetic autonomic neuropathy. 38
Hyperglycemia, Both Chronic and in Short-Term Peaks, Results in Rapid Increase of Expression of Monocyte Inducible Cyclooxygenase (COX-2) in Subjects with T2DM 38
L’ipoglicemia silente nella pratica clinica quotidiana: come diagnosticarla, gestirla e prevenirla 38
Comparative Effectiveness of Switching From First-Generation Basal Insulin to Glargine 300 U/ml or Degludec 100 U/ml in Type 1 Diabetes: The RESTORE-1 Study 38
Evaluation of the accuracy of a microdialysis-based glucose sensor during insulin-induced hypoglycemia, its recovery, and post-hypoglycemic hyperglycemia in humans. 37
Recovery and prevention of hypoglycaemia unawareness in Type 1 diabetes mellitus 37
Pharmacokinetics, pharmacodynamics, and modulation of hepatic glucose production with insulin glargine U300 and glargine U100 at steady state with individualized clinical doses in type 1 diabetes 37
Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis. 36
Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitus. 36
Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes. 36
Greater Suppression of Glucagon, Lipolysis, and Ketogenesis with Insulin Glargine U300 as Compared with Glargine U100 in Type 1 Diabetes Mellitus 36
INSULIN SENSITIVITY IN TYPE 2 DIABETIC PATIENTS IS DIFFERENT BETWEEN GLUCOSE AND PROTEIN METABOLISM 35
Low levels of unmodified insulin glargine in plasma of people with type 2 diabetes requiring high doses of basal insulin 35
Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes mellitus. 34
Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitus. 34
Pharmacokinetics and pharmacodynamics of NPH insulin in type 1 diabetes: The Importance of appropriate resuspension before subcutaneous injection 34
PHARMACOKINETIC AND PHARMACODYNAMIC HEAD-TO-HEAD COMPARISON OF CLINICAL, EQUIVALENT DOSES OF INSULIN GLARGINE 300 U/ML AND INSULIN DEGLUDEC 100 U/ML IN TYPE 1 DIABETES 34
Ricoveri per ipoglicemia grave in soggetti con diabete mellito di tipo 2: impatto clinico e costi sanitari 34
Metabolism of insulin glargine after repeated daily subcutaneous injections in subjects with type 2 diabetes. 33
null 32
Effect of sedentary behaviour and vigorous physical activity on segment-specific carotid wall thickness and its progression in a healthy population 32
Glargine metabolism over 24 h following its subcutaneous injection in patients with type 2 diabetes mellitus: A dose–response study 32
Insulin sensitivity and beta-cell function in the offspring of type 2 diabetic patients: impact of line of inheritance. 31
Pharmacokinetics and pharmacodynamics of basal insulins. 31
[Usefulness of plantar pressure measurement for the prevention and treatment of neuropathic diabetic foot]. 31
The effect of menopause on carotid artery remodeling, insulin sensitivity, and plasma adiponectin in healthy women 31
Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study. 30
Hypoglycemia 30
Obesity and carotid artery remodeling 30
One hour post-load plasma glucose and 3 year risk of worsening fasting and 2 hour glucose tolerance in the RISC cohort 30
Gamma-glutamyltransferase, arterial remodeling and prehypertension in a healthy population at low cardiometabolic risk 28
ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role? 28
Body composition and common carotid artery remodeling in a healthy population 27
Impact of family history on relations between insulin resistance, LDL cholesterol and carotid IMT in healthy adults 27
Physical activity and insulin sensitivity: the RISC study 27
Different insulin concentrations in resuspended vs. unsuspended NPH insulin: Practical aspects of subcutaneous injection in patients with diabetes. 27
Prevention and Management of Severe Hypoglycemia and Hypoglycemia Unawareness: Incorporating Sensor Technology 27
Insulin sensitivity and carotid intima-media thickness: relationship between insulin sensitivity and cardiovascular risk study. 26
From Metabolic Normality to Cardiometabolic Risk Factors in Subjects With Obesity 26
Insulin aspart improves meal time glycaemic control in patients with Type 2 diabetes: a randomized, stratified, double-blind and cross-over trial 24
Real-time continuous glucose monitoring decreases the risk of severe hypoglycemia in people with type 1 diabetes and impaired awareness of hypoglycemia 24
Impact of patient and treatment characteristics on glycemic control and hypoglycemia in patients with type 2 diabetes initiated to insulin glargine or NPH: A post hoc, pooled, patient-level analysis of 6 randomized controlled trials 24
Female Sex and Angiotensin-Converting Enzyme (ACE) Insertion/Deletion Polymorphism Amplify the Effects of Adiposity on Blood Pressure 24
Human Na + myo-inositol cotransporter gene: alternate spicing generates diverse transcripts 23
L’insulina biosimilare è “clinicamente uguale” all’originator, ma… 22
Ipoglicemia: implicazioni cliniche e impatto sulla salute 22
Switching from insulin bolus treatment to GLP-1 RAs added to continued basal insulin in people with type 2 diabetes on basal-bolus insulin 22
Shape of the OGTT glucose curve and risk of impaired glucose metabolism in the EGIR-RISC cohort 21
Metabolic effects of an SGLT2 inhibitor (Dapagliflozin) during a period of acute insulin withdrawal and development of ketoacidosis in people with type 1 diabetes. Diabetes care 2020;43:2128– 2136 21
Gli Analoghi dell’Insulina ad Azione Ritardo: dalla storia di ieri alle opzioni di oggi 20
Modification and validation of the triglyceride-to-HDL cholesterol ratio as a surrogate of insulin sensitivity in white juveniles and adults without diabetes mellitus: The single point insulin sensitivity estimator (SPISE) 20
How to accurately establish pharmacokinetics/ pharmacodynamics of long- Acting insulins in humans: Relevance to biosimilar insulins 19
Ipoglicemia: Implicazioni cliniche e impatto sulla salute 19
GLP-1 RAs as compared to prandial insulin after failure of basal insulin in type 2 diabetes: Lessons from the 4B and Get-Goal DUO 2 trials 18
Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes 18
Totale 4.090
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.879
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.879
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201932 0 0 0 0 0 0 0 0 0 0 23 9
2019/2020311 13 13 44 6 43 13 45 5 55 36 9 29
2020/2021818 5 49 41 44 247 71 49 13 96 37 64 102
2021/2022839 20 156 21 59 20 14 8 271 17 25 102 126
2022/20231.510 116 287 17 126 115 191 2 69 527 6 43 11
2023/2024369 36 76 35 11 5 7 121 2 44 28 4 0
Totale 4.280